Composition
- Active ingredients
- ATOGEPANT 30MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ATOGEPANT 30MG · TabletThis page
- ATOGEPANT 60MG · TabletNDA215206-003 · Prescription
- ATOGEPANT 10MG · TabletNDA215206-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA215206.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Qulipta
- Active substance
- atogepant
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Abbvie
- Status
- Prescription
- FDA approval
- 28 Sept 2021
- Application
- NDA215206-002